Spiriva and Transplant failure - a phase IV clinical study of FDA data

Summary:

Transplant failure is reported as a side effect among people who take Spiriva (tiotropium bromide monohydrate), especially for people who are female, 60+ old, also take Heparin, and have Pain.

The phase IV clinical study analyzes which people have Transplant failure when taking Spiriva. It is created by eHealthMe based on reports of 155,418 people who have side effects when taking Spiriva from the FDA, and is updated regularly.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.

What is Transplant failure?

Transplant failure (transplantation failed to meet outcome) is found to be associated with 198 drugs and 357 conditions by eHealthMe. Check the latest studies of Transplant failure.

On Aug, 08, 2026

155,418 people reported to have side effects when taking Spiriva.
Among them, 15 people (0.01%) have Transplant failure.

Among these 15 people:

What is the gender of people who have Transplant failure when taking Spiriva? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Transplant failure when taking Spiriva? *

What are other drugs people take besides Spiriva? *

What are other side effects people have besides Transplant failure? *

Confusional State: 6 people, 40.00%
Blood Creatinine Increased: 6 people, 40.00%
Acute Kidney Failure: 5 people, 33.33%
Sepsis (a severe blood infection that can lead to organ failure and death): 5 people, 33.33%
Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 33.33%
Epstein-Barr Virus Associated Lymphoproliferative Disorder (lymphocytes are produced in excessive quantities associated with epstein-barr virus): 5 people, 33.33%
Fever: 5 people, 33.33%
Fluid Overload (too much fluid in the blood): 5 people, 33.33%
Hepatitis (inflammation of the liver): 5 people, 33.33%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 5 people, 33.33%

What are the existing conditions these people have? *

Pain: 2 people, 13.33%
Stress And Anxiety: 1 person, 6.67%
Osteopenia (a condition where bone mineral density is lower than normal): 1 person, 6.67%
Nausea (feeling of having an urge to vomit): 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Interstitial Lung Disease: 1 person, 6.67%
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue): 1 person, 6.67%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva and have Transplant failure?

- Check whether Transplant failure is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Spiriva:

Spiriva (156,666 reports)

Transplant failure treatments and more:

Transplant failure (2,605 reports)

How severe was Transplant failure and when was it recovered:

Transplant failure in Spiriva

Expand to all the drugs that have ingredients of tiotropium bromide monohydrate:

Transplant failure and drugs with ingredients of tiotropium bromide monohydrate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Transplant failure:

Transplant failure (198 drugs)

Browse all the conditions that are associated with Transplant failure:

Transplant failure (357 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide monohydrate (the active ingredients of Spiriva) and Spiriva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.